Published online Apr 6, 2024. doi: 10.12998/wjcc.v12.i10.1742
Peer-review started: January 19, 2024
First decision: February 5, 2024
Revised: February 26, 2024
Accepted: March 12, 2024
Article in press: March 12, 2024
Published online: April 6, 2024
Processing time: 74 Days and 2.3 Hours
Speech disorders have a substantial impact on communication abilities and qua
To investigate the impact of TES in conjunction with standard therapies on serum neurotrophic factor levels and language function in patients with speech disor
In a controlled study spanning from March 2019 to November 2021, 81 patients with speech disorders were divided into a control group (n = 40) receiving standard speech stimulation and psychological intervention, and an observation group (n = 41) receiving additional TES. The study assessed serum levels of ciliary neurotrophic factor (CNTF), glial cell-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), and nerve growth factor (NGF), as well as evaluations of motor function, language function, and development quotient scores.
After 3 wk of intervention, the observation group exhibited significantly higher serum levels of CNTF, GDNF, BDNF, and NGF compared to the control group. Moreover, improvements were noted in motor function, cognitive function, language skills, physical abilities, and overall development quotient scores. It is worth mentioning that the observation group also displayed superior perfor
This retrospective study concluded that TES combined with traditional speech and psychotherapy can effectively increase the levels of neurokines in the blood and enhance language function in patients with speech disorders. These results provide a promising avenue for integrating TES into standard treatment methods for speech di
Core Tip: This study highlights the potential of transcranial electrical stimulation (TES) as a valuable additional therapy for individuals with speech disorders. Through the combination of TES with conventional speech and psychological inter